Interdomain communication regulating ligand binding by PPAR-γ

Nature

Volumn 396, Issue 6709, 1998, Pages 377-380

  Shao, Dalei ^a   Rangwala, Shamina M ^a   Bailey, Shannon T ^a   Krakow, Samuel L ^a   Reginato, Mauricio J ^a   Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

3T3 CELLS; ADIPOCYTES; ANIMALS; BINDING SITES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; HISTONE ACETYLTRANSFERASES; LIGANDS; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0032569902     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/24634     Document Type: Article

References (30)

1. Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1159 (1994).
2. Shao, D. & Lazar, M. A. PPARγ, C/EBPα, cell cycle status and the commitment to adipocyte differentiation. J. Biol. Chem. 272, 21473-21478 (1997).
3. Willson, T. M. et al. The structure-activity relationship between peroxisome proliferator-activated receptor γ and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665-668 (1996).
4. Altiok, S., Xu, M. & Spiegelman, B. M. PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987-1998 (1997).
5. Jiang, C., Tring, A. T. & Seed, B. PPAR-γ agonists inhibit productions of monocyte inflammatory cytokines. Nature 391, 82-86 (1998).
6. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82 (1998).
7. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. & Evans, R. M. Oxidized LDL regulates macrophage gene expression through activation of PPARγ. Cell 93, 229-240 (1998).
8. Tontonoz, P et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl Acad. Sci. USA 94, 237-241 (1997).
9. Yu, K. et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975-23983 (1995).
10. Kliewer, S. A. et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819 (1995).
11. Forman, B. M. et al. 15-deoxy, delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812 (1995).
12. Lehman, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956 (1995).
13. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406-3410 (1997).
14. Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell 83, 835-839 (1995).
15. Wurtz, J. M. et al. A canonical structure for the ligand binding domain of nuclear receptors. Nature Struct. Biol. 3, 87-94 (1996).
16. Camp, H. S. & Tafuri, S. R. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 13452-13457 (1997).
17. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A. & Chatterjee, V. K. Transcriptional activation by PPARγ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132 (1997).
18. Hu, E., Kim, J. B., Sarraf, P. & Spiegelman, B. M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 2100-2103 (1992).
19. Allan, G. F. et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267, 19513-19520 (1992).
20. Berger, J. et al. Thiazolidinediones produce a conformational change in peroxisome proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137, 4189-4195 (1996).
21. Lavinsky, R. M. et al. Diverse signalling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl Acad. Sci. USA 95, 2920-2925 (1998).
22. Refetoff, S., Weiss, R. E. & Usala, S. J. The syndromes of resistance to thyroid hormone. Endocrine Rev. 14, 348-399 (1993).
23. Reginato, M. J., Krakow, S. L., Bailey, S. T. & Lazar, M. A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J. Biol. Chem. 273, 1855-1858 (1998).
24. McBroom, L. D. B., Flock, G. & Giguere, V. The nonconserved hinge region and distinct aminoterminal domains of the RORα orphan nuclear receptor isoforms are required for proper DNA bending and RORα-DNA interactions. Mol. Cell. Biol. 15, 796-808 (1995).
25. Tzagarakis-Foster, C. & Privalsky, M. L. Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J. Biol. Chem. 273, 10926-10932 (1998).
26. Bunone, G., Briand, P. A., Miksicek, R. J. & Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183 (1996).
27. Kato, S. et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494 (1995).
28. McInerney, E. M., Tsai, M. J., O'Malley, B. W. & Katzenellenbogen, B. S. Analysis of estrogen receptor transcriptional enhancement by steroid hormone receptor coactivator. Proc. Natl Acad. Sci. USA 93, 10069-10073 (1996).
29. Schwarz, E. J., Reginato, M. J., Shao, D., Krakow, S. L. & Lazar, M. A. Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription. Mol. Cell. Biol. 17, 1552-1561 (1997).
30. Krey, G. et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791 (1997).